Prescribing Opioid Analgesics: General Precautions
Prescribing opioids are not without risks. However, opioids continue to be prescribed for acute and chronic pain given that they have been shown to be an effective treatment for certain individuals. Consistent with all prescribed medications, it is important for the prescriber to be aware of common side effects and their management, as well as potential serious side effects and their management. These recommendations are designed to minimize harm to the patient, their loved ones/caregivers, as well as to inform the prescriber about best practices. This session will provide clinicians with an overview of general precautions necessary when prescribing opioids.
- Summarize counseling strategies for patients on opioid therapy.
- Recognize signs of an opioid overdose.
Charles E. Argoff, MD, FABPM
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Katherine E. Galluzzi, DO, CMD, FACOFP
Professor and Chair
Department of Geriatrics
Philadelphia College of Osteopathic Medicine
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Charles E. Argoff, MD: Advisor for BioDelivery Sciences International, Inc.; Clexio Bioscience; Neumentum; Nevro; Regeneron Pharmaceuticals; SK Life Sciences; Tremeau Pharmaceuticals Inc.; Teva Pharmaceuticals; and Vertex. Consulting for EnZen; Opioid PMR Consortium; and Xgene. Services Provided for Collegium.
Katherine E. Galluzzi, DO, CMD, FACOFP: No relevant financial relationships disclosed.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
AMA PRA Category 1 Credits™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and Miller Medical Communications. Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.
Pri-Med Institute designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Pri-Med Institute and Miller Medical Communications. Pri-Med Institute is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number 040308.
This activity is approved for 0.50 contact hour of continuing education, which includes 0.00 hours of pharmacology.
- 0.50 AANP Contact Hours
- 0.50 AMA PRA Category 1 Credit™
This course is offered through Pri-Med.
To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch